Table 1 Clinicopathologic details of patient cohort

From: The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue

 

No. of patients ( n =254)

%

Age (years)

 Median

64

 

 Range

35–80

 

Gender

 Male

149

58.7

 Female

105

41.3

Tumour site

 Colon

183

72.0

 Rectum

71

28.0

UICC stage

 Stage II

163

64.2

 Stage III

91

35.6

Histological grade

 I

19

6.3

 II

197

77.6

 III

30

11.8

 Not stated

9

3.5

Received adjuvant treatment

 Yes

127

50.0

 No

127

50.0

Recurrence

 Yes

163

64.2

 No

91

34.8

Status at last review

 Alive

148

58.2

 Dead-all causes

106

41.8

 Dead-from CRC

85

33.5